How Much Should Governments Pay For COVID-19 Monoclonal Antibody Therapies?

 
• By Cathy Kelly
  
Medical engineering concept_227959225_1200.jpg
Monoclonal Antibody Drugs For COVID-19 Advancing Rapidly
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from COVID-19

More from Scrip